biotech - search results
If you're not happy with the results, please do another search
Biotech Sector ETF Breaks Price Support, Downside Target In View
The biotechnology industry appears to have completed a transition from accumulation to consolidation to distribution.
A confluence of price support levels around $125 for the...
Biotechnology Sector (IBB) Surges to New All-Time Highs
A week ago, I wrote a blog called The Beauty of the Biotechnology ETF Channel.
I began by writing, “If there is one area to watch should...
The Beauty of the Biotechnology ETF (IBB) Price Channel
If there is one area to watch should the stock market have another run up, it is the Biotechnology Sector NASDAQ: IBB.
The channel lines...
Big Brother Biotechnology Sector ETF (IBB): How Big is Big?
Today, the ETF that holds Biogen, Regeneron, Amgen, Gilead as four of the top ten in its basket, sits near the low price from...
Biotech Sector Getting Back on the Bullish Track
This article is a collaboration between between Arun Chopra (@FusionPtCapital) and Aaron Jackson (@ATMcharts).
Biotech had a banner week, leading the market after a base breakout on news. Let’s dig...
Stocks Decline: Here’s What Biotechnology Is Telling Investors?
If you are new to the blog, we all like to write about the macro picture using what I call the Economic Modern Family.
This...
Cryoport (CYRX): A Way To Bet On Biotech Without Event Risk
Small Cap Stock Research: Cryoport (CYRX)
Cryoport is a $390M provider of logistics solutions to the life sciences industry.
Shares of Cryoport (CYRX) are +72.85% YTD.
CYRX...
DeMark Indicators Could Spell Trouble For Biotech Stocks
Biotech stocks and the Biotech Sector have been a volatile space for investors this year. One month they are rallying, the next they are...
Biotech ETF (IBB) Investing Update: ‘The Trifecta From Hell’
No secret that counting on the predictability of prescription drug prices is slightly less reliable than playing roulette. However, until recently, Wall Street’s animal...
An Inside Look At The Rally In Biotech and Pharmaceutical Stocks
Last fall, we laid out the foundation for the current rally in pharmaceutical and biotech stocks; we take stock of those setups and the...
